COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,822 Articles (22,968 medRxiv, 8,854 bioRxiv)

Most recent first Previous |  Page 1668: Articles 16671-16680  | Next

The impact of real-time whole genome sequencing in controlling healthcare-associated SARS-CoV-2 outbreaks
Billam, H., Francis, R. V., Clarke, M., Yates, C., Tsoleridis, T., Berry, L., Mahida, N., Irving, W. L., Moore, C., Holmes, N., Ball, J., McClure, C. P., Loose, M., The COG-UK consortium
10.1101/2021.04.15.21253894 — Posted: 2021-04-17
Can Social Media Data Be Utilized to Enhance Early Warning: Retrospective Analysis of the U.S. Covid-19 Pandemic
Li, L., Gao, L., Zhou, J., Ma, Z., Choy, D., Hall, M.
10.1101/2021.04.11.21255285 — Posted: 2021-04-17
The Community Opinions on Vaccine Issues and Decisions (COVID) Survey: Using a rapid Knowledge, Attitude and Practice (KAP) survey in supporting a community engagement approach to address COVID-19 vaccine uptake initiatives.
Rahman, N.
10.1101/2021.04.11.21255260 — Posted: 2021-04-17
Declines in life expectancy following the COVID-19 pandemic in provinces of Spain
Trias-Llimos, S., Blanes, A., Franco, M., Bilal, U., Riffe, T.
10.1101/2021.04.15.21255545 — Posted: 2021-04-17
Using rapid (point-of-care) tests for COVID-19: A decision analysis comparing the expected benefit of two screening strategies
Baillargeon, R. H., Seyer, X., Bernard-Bedard, E.
10.1101/2021.04.15.21255569 — Posted: 2021-04-17
Evaluating Vaccine Efficacy Against SARS-CoV-2 Infection
Lin, D., Gu, Y., Zeng, D., Janes, H., Gilbert, P.
10.1101/2021.04.16.21255614 — Posted: 2021-04-17
Antibody Cocktail Exhibits Broad Neutralization against SARS-CoV-2 and SARS-CoV-2 variants
Qu, Y., Zhang, X., Wang, M., Sun, L., Jiang, Y., Li, C., Wu, W., Chen, Z., Yin, Q., Jiang, X., Liu, Y., Li, C., Li, J., Ying, T., Li, D., Zhan, F., Wang, Y., Guan, W., Wang, S., Liang, M.
10.1101/2021.04.16.440083 — Posted: 2021-04-17
SARS-CoV-2 proteins bind heme and hemoglobin
De-Simone, S. G., Lechuga, G. C., Souza-Silva, F., Sacramento, C. d. Q., Trugilho, M. R. d. O., Valente, R. H., Napoleao-Pego, P., Dias, S. d. S. G., Fintelman-Rodrigues, N., Temerozzo, J. R., Carels, N., Alves, C. R., Pereira, M. C. d. S., Provance-Jr, D. W., De-Simone, T. M.
10.1101/2021.04.16.440124 — Posted: 2021-04-16
Homo-harringtonine (HHT) - A highly effective drug against coronaviruses and the potential for large-scale clinical applications
Wen, H.-J., Lin, P., Zhong, G.-X., Xu, Z.-C., Shuai, L., Wen, Z.-Y., Wang, C., Cao, X., He, W.-B., Feng, J., Cai, Q.-C., Ma, H.-J., Wu, S.-J., Wang, G.-D., Lyu, X.-M., Liu, F.-L., Zheng, Y.-T., Zeng, H., He, X.-L., Chen, H.-L., Zhang, F.-J., Wu, C.-I.
10.1101/2021.04.16.440104 — Posted: 2021-04-16
Potential transmission chains of variant B.1.1.7 and co-mutations of SARS-CoV-2
Zhang, J., Zhang, Y., Kang, J., Chen, S., He, Y., Han, B., Liu, M., Lu, L., Li, L., Yi, Z., Chen, L.
10.1101/2021.04.16.440141 — Posted: 2021-04-16 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).